$Astellas Pharma (4503.JP)$ Astellas has been approved in th...
Astellas has been approved in the United States as a treatment for age-related macular degeneration, which causes poor eyesight.
As a result, the stock price went up a lot 😊
When it comes to age-related macula, it damages the retina and leads to poor eyesight.
What suppresses that damage is this medicine, and it's a very new drug 😊
Astellas had ophthalmology-related research and acquisitions of related companies for a long time, so I was really looking forward to it 😊
Moreover, eye diseases are in demand by many people, and I think they will be closely related to everyday life in the future, like lifestyle diseases 😊
So, it's strong to be able to monopolize this field for a while with this new drug 😊
Since stable profits can also be made, I think shareholder returns will also be actively promoted 😊
I really want companies that develop drugs for such intractable diseases to do their best, and I want to support them 👍
I want to keep getting really excited 😊
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
一日の中で重要な投資ニュースを１分で学べるように解説中。
普段はインスタグラムで節約や投資の発信をしてるので遊びにきてね
572Followers
19Following
2028Visitors
Follow